Everolimus- vs. novolimus-eluting bioresorbable scaffolds in patients with acute coronary syndrome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Everolimus- vs. novolimus-eluting bioresorbable scaffolds in patients with acute coronary syndrome

Published:2019-06-17 Issue:S1 Volume:45 Page:95-104
ISSN:0340-9937
Container-title:Herz
language:en
Short-container-title:Herz

Author:

Nef H. M.,Wiebe J.,Schmidt G.,Möllmann H.,Boeder N. F.,Dörr O.,Bauer T.,Blachutzik F.,Liebetrau C.,Elsässer A.,Foin N.,Hamm C. W.

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00059-019-4822-7.pdf

Reference31 articles.

1. Wiebe J, Nef HM, Hamm CW (2014) Current status of bioresorbable scaffolds in the treatment of coronary artery disease. J Am Coll Cardiol 64(23):2541–2551. https://doi.org/10.1016/j.jacc.2014.09.041

2. Ali ZA, Gao R, Kimura T et al (2018) Three-year outcomes with the absorb bioresorbable scaffold: individual-patient-data Meta-analysis from the ABSORB randomized trials. Circulation 137(5):464–479. https://doi.org/10.1161/CIRCULATIONAHA.117.031843

3. Cassese S, Byrne RA, Ndrepepa G et al (2016) Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials. Lancet 387(10018):537–544. https://doi.org/10.1016/S0140-6736(15)00979-4

4. Nef HM, Wiebe J, Foin N et al (2017) A new novolimus-eluting bioresorbable coronary scaffold: present status and future clinical perspectives. Int J Cardiol 227:127–133. https://doi.org/10.1016/j.ijcard.2016.11.033

5. Costa J, Ormiston J, Abizaid A et al (2012) TCT-298 six-month Intravascular ultrasound analysis of the DEsolve FIM trial with a novel PLLA-based fully biodegradable drug-eluting scaffold. J Am Coll Cardiol 60(17_S). https://doi.org/10.1016/j.jacc.2012.08.322

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Latest generation stents: is it time to revive the bioresorbable scaffold?;Minerva Cardioangiologica;2020-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3